Clinical Trials Browser

Phase 3 × Recruiting × polatuzumab vedotin × Clear all

NCT06522555 2024-08-05

The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse